Jasmine Zunic

Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms

Kayo Sakaguchi, Mitchell Green, Nicholas Stock et al. · Archives of Biochemistry and Biophysics · 2004 · 111 citations

Life Sciences, Biochemistry, Chemistry +10

5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- <i>tert</i> -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 <i>H</i> -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor

Nicholas Stock, Gretchen Bain, Jasmine Zunic et al. · Journal of Medicinal Chemistry · 2011 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation

Daniel S. Lorrain, Gretchen Bain, Lucia Correa et al. · European Journal of Pharmacology · 2010 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +15

5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—A potent FLAP inhibitor

Nicholas Stock, Christopher Baccei, Gretchen Bain et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 21 citations · Full text

Life Sciences, Biochemistry, Pharmacology +10

Pharmacodynamics, pharmacokinetics and safety of <scp>GSK</scp>2190915, a novel oral anti‐inflammatory 5‐lipoxygenase‐activating protein inhibitor

Gretchen Bain, Christopher D. King, Kevin M. Schaab et al. · British Journal of Clinical Pharmacology · 2012 · 19 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13